US FDA Panel Divided In Support Of Ipsen’s Rare Bone Disorder Drug Palovarotene

 
• By Brenda Sandburg
  
Bone disorder
Drug to treat rare bone growth disorder gets mixed review from FDA advisory committee. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers